Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 50 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

32%

16 trials in Phase 3/4

Results Transparency

9%

2 of 23 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

37Total
Not Applicable (16)
P 2 (5)
P 3 (5)
P 4 (11)

Trial Status

Completed23
Unknown11
Recruiting9
Active Not Recruiting3
Not Yet Recruiting3
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (50)

Showing 20 of 20 trials
NCT07487142Phase 3CompletedPrimary

Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding"

NCT05444439Not ApplicableCompletedPrimary

Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy

NCT06529159Not ApplicableRecruiting

H. Pylori Eradication With Argon Plasma During Endoscopy

NCT07224048Phase 4Active Not RecruitingPrimary

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

NCT07224035Phase 4Active Not RecruitingPrimary

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

NCT06045494Not ApplicableCompletedPrimary

The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21

NCT07293234Not ApplicableNot Yet RecruitingPrimary

Effect of Simethicone on Helicobacter Pylori Detection in Routine Endoscopy

NCT07306377CompletedPrimary

H. Pylori Infection and AIP Levels

NCT07289451Not ApplicableCompletedPrimary

TLR 9 (rs352140) Gene Polymorphism in Helicobacter Pylori Infection

NCT07179237Phase 2Recruiting

Efficacy of Carminal in Helicobacter Pylori Gastritis

NCT05387005Not ApplicableRecruitingPrimary

Screening Strategy for Gastric Cancer Prevention

NCT07045857Not ApplicableRecruitingPrimary

Recurrence of H Pylori : Incidence and Influential Factors.

NCT07045688Not ApplicableRecruitingPrimary

Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

NCT07012785Not ApplicableNot Yet RecruitingPrimary

Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori Infection

NCT05544396Not ApplicableActive Not RecruitingPrimary

Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.

NCT02328131RecruitingPrimary

European Registry on the Management of Helicobacter Pylori Infection

NCT06579365Recruiting

Argentinean Registry on the Management of Helicobacter Pylori Infection

NCT03340454Not ApplicableCompletedPrimary

Patient-Centered Cancer Prevention In Chinese Americans

NCT06412640Phase 4Not Yet RecruitingPrimary

Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori

NCT06304532CompletedPrimary

Clinical Efficacy and Safety Assessment of Alsareen Capsule for the Management of H. Pylori Infection

Scroll to load more

Research Network

Activity Timeline